Leaders Discuss Efforts to Modernize Clinical Research

Leaders discuss efforts to modernize clinical research. Guests: Dr. Janet Woodcock, FDA's top drug regulator. Dr. Garry Neil, acting CEO of TransCelerate Biopharma, and David Wholley, director of the Biomarkers Consortium for the FNIH.
http://www.biocenturytv.com/player/1914856854001/1915196047001?utm_mediu...

Building a Better Airplane

FDA's Dr. Janet Woodcock says I-Spy 2 is leading the way in clinical trial design. Using a an airplane metaphor, she describes the current trial system's challenges and why patient centric evaluation results in better outcomes.
http://www.biocenturytv.com/player/1914856854001/1915099973001?utm_mediu...

Missing Out?

Asked if patients are potentially missing out on new drugs due to the current trial system design, Transcelerate's Dr. Garry Neil says "I think it's absolutely right", going on to say the trials are too long, uncertain and cost too much.
http://www.biocenturytv.com/player/1914856854001/1915099974001?utm_mediu...

Staying Competitive

Foundation for NIH's David Wholley says the threat to national competitiveness can't be overstated when clincial research moves overseas. Transcelerate's Dr. Garry Neil agrees that a risk exists with other countries taking a more dominant role.
http://www.biocenturytv.com/player/1914856854001/1915138521001?utm_mediu...